Melanoma Clinical Trials in Dallas

Showing 261-268 of 268 trials

TNFerade™ Biologic Plus Radiation for Metastatic Melanoma

NCT00261404

Phase II, open label study in which patients with metastatic melanoma (stage III or IV) who have cancer which is not considered curable by surgery will receive intratumoral injections of TNFerade™ plus radiation as a 4-week treatment, followed by a 3 year follow-up period.

Melanoma

GenVec

Dallas, Texas, United States

COMPLETEDPhase 2< 1 mile

Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

NCT00289640

The purpose of this clinical research study is to compare the best overall response rate (BORR)(as per modified WHO criteria) in patients with previously treated, therapy-refractory, or -intolerant, Stage III (unresectable) or Stage IV melanoma receiving ipilimumab doses of 0.3, 3, and 10 mg/kg. The safety of this product will also be evaluated.

Melanoma

Bristol-Myers Squibb210 participantsStarted Apr 2006

Tucson, Arizona, United States • Laverne, California, United States • San Diego, California, United States +59 more locations

TNFerade™ Biologic Plus Radiation for Metastatic Melanoma

Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Melanoma Trials in Other Cities

A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma

Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma

Vaccine Therapy for Patients With Stage IV Melanoma

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

Long-term Data Collection for Subjects in MDX-010 Studies

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

Other Conditions in Dallas